Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
Bleyer
W A
WA
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D006801:Humans; D007278:Injections, Spinal; D008081:Liposomes; D008577:Meningeal Neoplasms / Q000188:drug therapy*; D008727:Methotrexate / Q000493:pharmacokinetics / Q000627:therapeutic use
D000964:Antimetabolites, Antineoplastic; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D008081:Liposomes; D003561:Cytarabine; D008727:Methotrexate